GGrantIndex
← Search

Phase I Clinical Trial Unit for Therapeutics - Phase I Trial for MERS-CoV

$59,564N01FY2016AINIH

Dynport Vaccine Company, Llc, Frederick MD

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

View original record on NIH RePORTER →
Phase I Clinical Trial Unit for Therapeutics - Phase I Trial for MERS-CoV · GrantIndex